NIFTY 50

Services to get impacted if COVID testing price is cut: Dr Lal Pathlabs

Updated : December 21, 2020 16:07:17 IST

Diagnostic companies are on radar given the recent fresh price cap on COVID-19 testing. Om Manchanda, MD of Dr Lal Pathlabs, on Monday said that they will continue to support the government when it comes to testing but pointed out that eventually, the cuts will impact services.

Speaking further in an interview to CNBC-TV18, he said, “Given our scale and portfolio we are managing it now, but any further cut in prices will hurt the entire industry as well as the company.”

He believes there are misconceptions around the pricing of COVID testing.

“There is a general misconception that a kit cost is equal to the cost of doing a test,” he added.

According to him, the non-COVID portfolio is important for the business. “We should see the normal trajectory of non-COVID testing by Q4,” Manchanda said.

For entire interview, watch the video
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you